The impact of disease severity on the informed consent process in clinical research
- 1 March 1996
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 100 (3), 261-268
- https://doi.org/10.1016/s0002-9343(97)89483-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factorAnti-Cancer Drugs, 1993
- Participation in biomedical research: The consent process as viewed by children, adolescents, young adults, and physiciansThe Journal of Pediatrics, 1992
- Ethical Dilemmas in HIV Infection: What Have We Learned?Law, Medicine and Health Care, 1992
- Empirical studies of ethical issues in research: A research agenda.American Psychologist, 1987
- Consent Forms, Readability, and Comprehension: The Need for New Assessment ToolsLaw, Medicine and Health Care, 1985
- Disclosure of Information to Patients in Medical CareMedical Care, 1981
- Informed Consent — Why Are Its Goals Imperfectly Realized?New England Journal of Medicine, 1980
- Assessment of preferences for self-treatment and information in health care.Journal of Personality and Social Psychology, 1980
- Patient recall of informed consentMedical and Pediatric Oncology, 1979
- Findings and Theory in the Study of Fear CommunicationsPublished by Elsevier BV ,1970